Faculty profile

Dennis Kim

Back to faculty

Associate ProfessorInstitute of Medical ScienceUniversity of Toronto

Dennis Kim

Associate Professor

Institute of Medical Science

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
6 publications in the last five years, latest in 2025.
Principal investigator on 1 research grant (1 CCS), most recently in 2019.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

190

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells
Blood · 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms.
European journal of haematology · 2025
Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients
European Journal Of Haematology · 2024

All 11 publications

Latest funding

Clonal stromapoiesis and BM microenvironment in leukemias and HCT
CCS · 2019 · Principal investigator
$200,000

All 1 grants and awards

11 publications.

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

Joana Araújo, Elvin Wagenblast, Véronique Voisin, Jessica L. McLeod, Olga I. Gan, Suraj Bansal, Liqing Jin, Amanda Mitchell, Blaise Gratton, Sarah K. Cutting, Andrea Arruda, Monica Doedens, Anthea Travas, Dennis Dong Hwan Kim, José‐Mario Capo‐Chichi, Sagi Abelson, Mark David Minden, Jean C. Y. Wang, Manuel Sobrinho Simões, Perpétua Pinto‐do‐Ó, Eric R. Lechman, John Edgar Dick

Blood202511 citationsOpen Access

DOI: 10.1182/blood.2024025886 PMID: 39841016

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms.

Desai N, Rodriguez-Rodriguez S, Chen C, Moya TA, Al-Shaibani E, Novitzky-Basso I, Pasic I, Michelis FV, Viswabandya A, Kim D, Kumar R, Mattsson J, Law AD

European journal of haematology202510 citationsOpen Access

DOI: 10.1111/ejh.14430 PMID: 40337996

Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients

Camille C.B. Kockerols, Peter J.M. Valk, Jeroen J. W. M. Janssen, Pauline Hogenbirk, Jan J. Cornelissen, Susanne Saußele, Birgit Spieß, María Agustina Perusini, Dennis Dong Hwan Kim, Peter E. Westerweel

European Journal Of Haematology20247 citationsOpen Access

DOI: 10.1111/ejh.14271 PMID: 38994654

Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.

Madsen K, Lee K, Chen S, Chen C, Law AD, Gerbitz A, Kumar R, Kim D, Lam W, Pasic I, Viswabandya A, Michelis FV, Nampoothiri RV, Lipton JH, Novitzky-Basso I, Mattsson J

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer20234 citations

DOI: 10.1007/s00520-023-08022-9 PMID: 37676349

Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.

Vasudevan Nampoothiri R, Tang K, Schuh A, Lam W, Maze D, Michelis FV, Chan S, Gupta V, Kim D, Kumar R, Lipton JH, Mattsson J, Minden M, Schimmer A, Sibai H, Viswabandya A, Yee K, Murphy T, Law AD

European journal of haematology2023Open Access

DOI: 10.1111/ejh.13940 PMID: 36732677

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.

Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J

Transplantation and cellular therapy202239 citationsOpen Access

DOI: 10.1016/j.jtct.2021.10.008 PMID: 34656808

Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.

Smith E, Huang J, Viswabandya A, Maze D, Malik S, Cheung V, Siddiq N, Claudio J, Arruda A, Kennedy J, Bankar A, Law AD, Lam W, Michelis FV, Kim D, Lipton J, Kumar R, Mattsson J, McNamara C, Sibai H, Xu W, Gupta V

Transplantation and cellular therapy20218 citationsOpen Access

DOI: 10.1016/j.jtct.2021.03.027 PMID: 33798769

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation201446 citationsSenior authorOpen Access

DOI: 10.1016/j.bbmt.2014.01.010 PMID: 24447907

Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.

Hamad N, Del Bel R, Messner HA, Kim D, Kuruvilla J, Lipton JH, Uhm J, Seftel M, Alam N, Xu W, Gupta V

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation201413 citationsOpen Access

DOI: 10.1016/j.bbmt.2014.06.033 PMID: 25017761

Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease.

Alam N, Atenafu EG, Tse G, Viswabandya A, Gupta V, Kim D, Lipton JH, Messner HA, Kuruvilla J

Clinical transplantation201311 citations

DOI: 10.1111/ctr.12268 PMID: 24304375

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Dennis Kim

Research

Latest papers

Latest funding

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms.

Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients

Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.

Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.

Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.

Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease.

Clonal stromapoiesis and BM microenvironment in leukemias and HCT

Frequent collaborators

Auro Viswabandya

Vikas Gupta

Rajat Kumar

Jonas Mattsson

John Kuruvilla

Wilson Lam

Ivan Pasic

Mark Minden

Igor Novitzky-Basso

Dawn Maze

Hassan Sibai

Aniket Bankar

Jean Wang

Andre Schuh

Sagi Abelson

Aaron Schimmer

Tommy Moya

John Dick

Wei Xu

Steven Chan